TACSTD2 and colorectal carcinoma: Trerotola and colleagues showed that the extracellular portion of TROP2 in cancer cells is cleaved by the ADAM10 protease between residues arginine 87 and threonine 88 and that this modification is essential for the metastasis of KM12SM CRC cells [25].